Concepedia

Komal Kumar Javarappa

KK

Statistics

Publications

7

Citations

471

H-Index

7

Active since

2017

Affiliations

University of Helsinki(Current)

Institute for Molecular Medicine Finland

Helsinki University Hospital

Aalto University

University of Copenhagen

Komal Kumar Javarappa is an author at University of Helsinki specializing in medicine, oncology, and molecular oncology.

Publications per year

2017–2022

7

Publications

7

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Heikki Kuusanmäki, Olli Dufva, Markus Vähä‐Koskela et al. · Blood · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +16

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

Riikka Karjalainen, Tea Pemovska, Mihaela Popa et al. · Blood · 2017 · 123 citations · Full text

Medicine, Cancer Biology, Hematology +13

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets

Shady Adnan Awad, Daehong Kim, Helena Hohtari et al. · Leukemia · 2020 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

Jarno Kivioja, Angeliki Thanasopoulou, Ashwini Kumar et al. · Leukemia · 2018 · 61 citations

Medicine, Oncology, Pharmacotherapy +10

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations

Aleksandr Ianevski, Jenni Lahtela, Komal Kumar Javarappa et al. · Science Advances · 2021 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7